49 unknown. 49 Phase 3, 10 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 49 | Unknown 49 |
| Phase 2 | 10 | Unknown 10 |
Follow Embolism and Thrombosis: new trials by email Literature Review of Embolism and Thrombosis trials Research Report on Embolism and Thrombosis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Anti-Xa Guided Dosing of Low Molecular Weight Heparin for Prevention of Venous Thromboembolism Following Traumatic Injury: a Multicentre Pilot Randomized Trial Anti-Xa Guided Dosing of Low Molecular Weight Heparin, Standard of Care Dosing - Venous Thromboembolism (VTE), Trauma Related Injuries | Phase 2 / Phase 3 | Unknown | Alexandre Tran | 150 | 2025-01-01 | 2024-10-28 |
| Evaluation of Therapeutic Efficacy of Faricimab for Clinical AMD, DME, and RVO Patients Faricimab - Age-Related Macular Degeneration, Diabetic Macular Edema | Phase 2 / Phase 3 | Unknown | Second Affiliated Hospital, Zhejiang University, School of Medicine | 30 | 2024-03-01 | 2024-08-27 |
| The Use of N-acetylcysteine for Thrombotic Events After Allogenic Hematopoietic Stem Cell Transplantation N-acetyl-cysteine, Busulfan, Cytarabine - Thrombotic Disorder | Phase 3 | Unknown | The First Affiliated Hospital of Soochow University | 260 | 2023-08-01 | 2023-06-18 |
| The Effectiveness and Safety of 4% Sodium Citrate as a Lock Solution in Central Venous Hemodialysis Catheter 4% sodium citrate, heparin group - Central Venous Catheter Thrombosis, Renal Dialysis | Phase 2 / Phase 3 | Unknown | Chang Gung Memorial Hospital | 120 | 2022-07-20 | 2022-07-25 |
| The Impact of Thromboprophylaxis on Progression Free Survival of Patients With Advanced Pancreatic Cancer Innohep, Chemotherapy: Gemcitabine + Nab-Paclitaxel - Pancreatic Cancer, Thromboembolism | Phase 3 | Unknown | Michalis Karamouzis | 450 | 2022-02-10 | 2022-03-29 |
| The MUFFIN-PTS Trial Micronized Purified Flavonoid Fraction, Placebo - Post-Thrombotic Syndrome | Phase 3 | Unknown | Sir Mortimer B. Davis - Jewish General Hospital | 88 | 2022-02-04 | 2023-11-30 |
| Tumescent Anesthesia Antibiotic Delivery (TAAD) Tumescent Anesthesia and antibiotic delivery (TAAD) plus IVAD, SubQKath - Surgical Site Infection, Thrombosis | Phase 2 / Phase 3 | Unknown | HK Surgical, Inc. | 330 | 2021-12-01 | 2021-02-02 |
| Prophylactic vs Therapeutic Anticoagulation in Symptomatic Isolated Distal Deep Vein Thrombosis Rivaroxaban - Venous Thrombosis | Phase 3 | Unknown | Shanghai Zhongshan Hospital | 480 | 2021-08-01 | 2022-02-16 |
| Dabigatran Versus Apixaban in Cerebral Venous Thrombosis Dabigatran Etexilate 150mg, Apixaban 5MG - Cerebral Venous Sinus Thrombosis | Phase 3 | Unknown | Kafrelsheikh University | 200 | 2021-08-01 | 2024-08-13 |
| Rivaroxaban Versus Apixaban in Cerebral Venous Thrombosis Apixaban 5MG, Rivaroxaban 20 MG Oral Tablet - Cerebral Venous Thrombosis | Phase 3 | Unknown | Kafrelsheikh University | 200 | 2021-08-01 | 2024-08-19 |
| Venous Thromboembolism Prophylaxis After Gynecological Pelvic Cancer Surgery With Rivaroxaban vs Enoxaparin Rivaroxaban, Enoxaparin - Cancer, Rivaroxaban | Phase 3 | Unknown | André Luiz Malavasi Longo de Oliveira | 440 | 2020-10-22 | 2021-08-10 |
| Prasugrel in Severe COVID-19 Pneumonia Prasugrel Hydrochloride 10 MG Oral Tablet, Placebo - COVID19, Thrombosis | Phase 3 | Unknown | Azienda Ospedaliera Universitaria Integrata Verona | 128 | 2020-07-01 | 2020-06-26 |
| Rivaroxaban and Vitamin K Antagonists for the Anticoagulation for the Implantation of Vena Cava Filters Rivaroxaban, Warfarin, Nadroparin - Venous Thromboembolism | Phase 3 | Unknown | Second Affiliated Hospital, Zhejiang University, School of Medicine | 200 | 2020-05-08 | 2024-04-18 |
| Rivaroxaban for Thromboprophylaxis in High-risk Cancer Patients With Totally Implantable Access Ports Rivaroxaban - Rivaroxaban, Thromboprophylaxis | Phase 3 | Unknown | LiuZhou People's Hospital | 204 | 2020-03-08 | 2020-03-16 |
| Impact of Early Debriefing and Enhanced Educative Components on Direct Oral Anticoagulant Adherence After Venous Thromboembolism. Debriefing and educative components, Without debriefing and educative components - Venous Thromboembolism | Phase 3 | Unknown | University Hospital, Brest | 150 | 2019-12-27 | 2020-12-02 |
| Rotterdam EDOXaban Leaflet Evaluation in Patients After Transcatheter Aortic Valve Implantation Edoxaban - Aortic Valve Stenosis | Phase 3 | Unknown | Erasmus Medical Center | 100 | 2019-08-01 | 2022-07-27 |
| Efficacy of Apixaban in Malignancy With Deep Venous Thrombosis Apixaban, Enoxaparin - Deep Vein Thrombosis, Malignancy | Phase 3 | Unknown | Beni-Suef University | 100 | 2019-07-03 | 2020-07-08 |
| Functional Training for the Prevention of Deep Venous Thrombosis passive ankle pump motions on the day of surgery, active ankle pump motions and abdominal breathing training on the 1-3 day after the surgery, Regular care - Ankle Motion, Gynecologic Neoplasm | Phase 3 | Unknown | Lei Li | 398 | 2018-11-10 | 2018-11-14 |
| Hydroxychloroquine Versus Placebo: Impact on Thrombotic Relapse in Primary Antiphospholipid Syndrome Hydroxychloroquine, Placebo - Primary Antiphospholipid Syndrome | Phase 3 | Unknown | University Hospital, Angers | 300 | 2018-08-15 | 2018-05-30 |
| Tecarfarin Anti-Coagulation Trial (TACT) Warfarin, tecarfarin - Thromboembolism, Thrombosis | Phase 3 | Unknown | Espero Biopharma | 1000 | 2018-06-01 | 2018-01-25 |
Showing 20 of 49. Sign in to see all of them.
Thrombosis (14) · Venous Thromboembolism (11) · Venous Thrombosis (11) · Retinal Vein Occlusion (5) · Thromboembolism (5) · Pulmonary Embolism (4) · Atrial Fibrillation (3) · Intracranial Thrombosis (3) · Neoplasms (3) · Thrombophilia (3) · Aortic Valve Stenosis (2) · Intracranial Embolism (2) · Macular Edema (2) · Raynaud Disease (2) · Scleroderma, Diffuse (2)
Cardiovascular Diseases (48) · Vascular Diseases (48) · Thrombosis (19) · Thromboembolism (16) · Pathologic Processes (10) · Pathological Conditions, Signs and Symptoms (10) · Nervous System Diseases (7) · Venous Thrombosis (7) · Brain Diseases (6) · Central Nervous System Diseases (6) · Cerebrovascular Disorders (6) · Lung Diseases (6) · Respiratory Tract Diseases (6) · Eye Diseases (5)
Rivaroxaban (6) · Dabigatran (4) · Enoxaparin (3) · Warfarin (3) · apixaban (3) · Aspirin (2) · Clopidogrel (2) · Dalteparin (2) · Nadroparin (2) · Nitroglycerin (2) · Ranibizumab (2) · Tinzaparin (2) · 1,3,4,6-tetra-O-acetyl-2-azido-2-deoxyglucopyranose (1) · 130-nm albumin-bound paclitaxel (1) · Acetylcysteine (1)
Azidus Brasil (2) · Kafrelsheikh University (2) · MediQuest Therapeutics (2) · Second Affiliated Hospital, Zhejiang University, School of Medicine (2) · Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) (1) · Ahmed AbdelMoneim Hassan Ali (1) · Alexandre Tran (1) · André Luiz Malavasi Longo de Oliveira (1) · Assistance Publique - Hôpitaux de Paris (1) · Azienda Ospedaliera Universitaria Integrata Verona (1) · Beni-Suef University (1) · Capital Medical University (1) · Chang Gung Memorial Hospital (1) · Charite University, Berlin, Germany (1) · Copenhagen University Hospital, Rigshospitalet (1)
China (5) · Brazil (4) · Canada (4) · Egypt (3) · France (3) · Italy (3) · Netherlands (3) · United States (3) · South Korea (2) · Austria (1) · Denmark (1) · Germany (1) · Greece (1) · Hong Kong (1) · India (1)
Ahmed AH Hassan Ali, master (1) · Alexandre Tran, MD, MSc, FRCSC (1) · Antoni Sabate, MD (1) · Atar Shaul, MD (1) · Bernd Poetzsch, Professor (1) · Cecilia Becattini, MD (1) · Cristina Belizna, MD, PhD (1) · David Wong, MD (1) · Eduardo Ramacciotti, MD, PhD (1) · Fergus Macbeth, MD (1) · Giancarlo Agnelli, MD (1) · Gloria Hwang, MBBS (1) · Jae Pil Shin, M.D. (1)
PMID 31867054, PMID 10737280, PMID 10963635, PMID 12393647, PMID 18190818, PMID 19807917, PMID 22540524, PMID 22621626, PMID 22898071, PMID 23702623, PMID 23725876, PMID 25012265, PMID 26002690, PMID 26407753, PMID 26867832, PMID 26880105, PMID 28279428, PMID 28373761, PMID 28990201, PMID 30027281, PMID 30103252, PMID 30918939, PMID 31504429, PMID 31630479, PMID 33153401, PMID 33337539, PMID 34108229, PMID 34518263, PMID 34622445, PMID 34632490, PMID 34697109, PMID 34878173, PMID 35089599, PMID 35228291, PMID 35787831, PMID 35876829, PMID 36520715, PMID 37489818, PMID 37919695, PMID 39152310, PMID 39575924
2016 (1), 2017 (1)